{"doi":"10.1016/j.bmcl.2014.08.046","title":"Selective inhibitors of the Janus kinase Jak3—Are they effective?","abstract":null,"journal":"Bioorganic & Medicinal Chemistry Letters","year":2014,"id":618241,"datarank":0.6141516843333151,"base_score":4.0943445622221,"endowment":4.0943445622221,"self_citation_contribution":0.6141516843333151,"citation_network_contribution":0.0,"self_endowment_contribution":0.6141516843333151,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":59,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1594783,"name":"Peter Drückes","orcid":null,"position":1,"is_corresponding":false},{"id":1594784,"name":"Hans-Günter Zerwes","orcid":null,"position":2,"is_corresponding":false},{"id":1594782,"name":"Gebhard Thoma","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Selective inhibitors of the Janus kinase Jak3—Are they effective?","abstract":"Jak3, together with Jak1, is involved in signal transduction initiated by cytokines signaling through the common gamma chain which are important in immune homeostasis and immune pathologies. Based on genetic evidence Jak3 has been considered to be an attractive target for immunosuppression. The Jak inhibitor tofacitinib (CP-690,550) which is an approved drug for rheumatoid arthritis was originally introduced as a selective Jak3 inhibitor, however, it also inhibits Jak1 and Jak2. The search for new selective Jak3 inhibitors has yielded several compounds whose profiles will be reviewed here. Implications on Jak3 as a therapeutic target are also discussed.","is_dataset_classified":null,"base_score":4.0943445622221,"endowment":4.0943445622221,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25217444","pmcid":null,"openalex_id":"https://openalex.org/W2083337211","authors":[],"funders":[],"total_grants":0,"fwci":2.8985,"citation_percentile":0.9246655,"influential_citations":0,"citation_trend":[{"year":2015,"count":5},{"year":2016,"count":11},{"year":2017,"count":5},{"year":2018,"count":6},{"year":2019,"count":7},{"year":2020,"count":7},{"year":2021,"count":4},{"year":2022,"count":2},{"year":2023,"count":2},{"year":2024,"count":5},{"year":2025,"count":4},{"year":2026,"count":1}],"oa_status":"closed","license":"https://doi.org/10.15223/policy-004","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0960894X14008907?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X14008907?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bmcl.2014.08.046","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25217444","host_type":"repository"}],"fields_of_study":["Cytokine Signaling Pathways and Interactions","Pharmacological Effects of Natural Compounds","Systemic Lupus Erythematosus Research"],"mesh_terms":["Animals","Humans","Structure-Activity Relationship","Molecular Structure","Protein Kinase Inhibitors","Janus Kinase 3"],"keywords":["Tofacitinib","Janus kinase 3","Janus kinase","Chemistry","Immune system","Rheumatoid arthritis","Immunosuppression","Pharmacology","Signal transduction","Immunology","Biochemistry","Medicine","Interleukin 12","In vitro","Cytotoxic T cell","Selectivity","Jak3","Janus Kinase Inhibitors","Jak1"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T03:48:32.375194Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}